Finance

Lists
CSBR:NASDAQ
Champions Oncology Inc
USD 4,68
0,00%
(0,00) 1D
16 Nov., 15:19:28 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSBR...
Mkt. cap
65,14 m
Avg. vol.
7,80 k
Volume
8,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Mkt. cap
65,14 m
Avg. vol.
7,80 k
Volume
8,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
USD 12,00
+156,4%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
15,04 m
16,56 m
13,84 m
15,23 m
Cost of goods sold
7,26 m
8,83 m
6,81 m
7,53 m
Cost of revenue
7,26 m
8,83 m
6,81 m
7,53 m
Research and development expenses
2,62 m
2,27 m
2,12 m
2,34 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,97 m
5,64 m
5,43 m
5,76 m
Operating expense
7,59 m
7,91 m
7,55 m
8,11 m
Total operating expenses
14,85 m
16,75 m
14,36 m
15,64 m
Operating income
185,00 k
-187,00 k
-521,00 k
-409,00 k
Other non operating income
70,00 k
39,00 k
27,00 k
-6,00 k
EBT including unusual items
255,00 k
-237,00 k
-495,00 k
-415,00 k
EBT excluding unusual items
255,00 k
-148,00 k
-494,00 k
-415,00 k
Income tax expense
18,00 k
42,00 k
172,00 k
11,00 k
Effective tax rate
7,06%
-17,72%
-34,75%
-2,65%
Other operating expenses
-
-
-
-
Net income
268,00 k
-279,00 k
-667,00 k
-426,00 k
Net profit margin
1,78%
-1,68%
-4,82%
-2,80%
Earnings per share
0,06
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
542,00 k
154,00 k
-200,00 k
-95,00 k
Gain or loss from assets sale
-
90,00 k
1,00 k
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme